Cargando…
“Real‐world” eligibility for aducanumab depends on clinical setting and patients' journey
See related editorial by Lundebjerg et al.
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298825/ https://www.ncbi.nlm.nih.gov/pubmed/34750815 http://dx.doi.org/10.1111/jgs.17530 |
| Sumario: | See related editorial by Lundebjerg et al. |
|---|